In this regard, we recently provided evidence that NOD1-and/or NOD2-independent activation of RIPK2 caused experimental IBD through TLRs-induced pro-inflammatory cytokine responses (Watanabe et al., 2019). Here, NOD1 is linked to inflammatory bowel disease.